Cite
HARVARD Citation
Noack, S. et al. (n.d.). P483 Infliximab but not adalimumab drug levels predict faecal calprotectin response in Inflammatory Bowel Disease patients on dose-intensified anti-TNF therapy. Journal of Crohn's and colitis. pp. S471-S472. [Online].